GRIFOLS – Sharing a few words about small-volume parenteral manufacturing with Oriol Argemí, Oriol Prat and Marga Viñes
Click HERE to download the PDF
GRIFOLS IN CDMO MARKET & PARENTERAL TRENDS
Grifols is in the CDMO market because of our leadership in intravenous (IV) therapy and our focus on IV solutions, which is supported by deep knowledge in sterile manufacturing. With the extensive experience we have in producing our own parenteral drug products, we wanted to leverage these capabilities for customers in the pharma industry that have IV drug products but lack the specialized expertise and equipment, because these types of products are not part of their core businesses.
It is well established that parenteral drugs and therapeutic fluids require highly controlled, sterile process environments to be manufactured correctly and to current GMP standards. Processing parenteral drugs is extre ... ...